Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Cash on Hand 2020–2025
Eli Lilly and Company annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Eli Lilly and Company cash on hand as of December 31, 2025: 7.27B, a 122.37% increase year-over-year.
- Eli Lilly and Company cash on hand for 2025 were 7.27B, a 122.37% increase from 2024.
- Eli Lilly and Company cash on hand for 2024 were 3.27B, a 15.96% increase from 2023.
- Eli Lilly and Company cash on hand for 2023 were 2.82B, a 36.36% increase from 2022.
- Eli Lilly and Company cash on hand for 2022 were 2.07B.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eli Lilly and Company Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $7,268 |
| 2024 | $3,268 |
| 2023 | $2,819 |
| 2022 | $2,067 |
| 2021 | $3,819 |
| 2020 | $3,657 |
Eli Lilly and Company Cash on Hand — FAQ
Eli Lilly and Company (LLY) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's cash on hand history?
The chart and table above show Eli Lilly and Company's cash on hand by year and by quarter, including the growth rate.